Why the study?
The level of cardiovascular disease risk among Prolanis participants at the Limboto Community Health Center was not previously determined.
Cross-Sectional (n=66)
No
Most Prolanis participants at the primary care level in this Indonesian cohort had a low 10-year risk for cardiovascular events, though a significant subset remains at moderate to very high risk requiring targeted preventive interventions.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Malingkonor et al. (2026) conducted a cross-sectional in Cardiovascular disease risk (n=66). WHO/ISH Risk Prediction Chart Non-Laboratory (SEAR B) was evaluated on Level of cardiovascular disease risk in the next 10 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: